ECOR compared with GALT: revenue, margins and what each company keeps, and the suppliers and customers both name

ECORelectroCore, Inc.

Mkt capRevenueRevenue

GALTGalectin Therapeutics Inc

Mkt capRevenueRevenue

Compare

ECORelectroCore, Inc.

GALTGalectin Therapeutics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ECOR, solidGALT, dashed

Supply-chain overlap

Revenue flow

ECOR: latest quarter is a loss; flow not drawable. GALT: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ECOR 1

—Joerns Healthcareunlistedcustomer

Shared 0

No shared counterparties.

Only GALT 6

—Perspectum Diagnosticsunlistedsupplier

—Covance (now known as Fortrea)unlistedsupplier

—Dr. Ari Rosenbergunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Dr. Chetan Bettegowdaunlistedsupplier

2 more · GALT chain ›

ECORelectroCore, Inc.

7.50▼−7.52%· post 7.50

Mkt cap$67.8MRevenue$9MQ2 FY26Revenue$32MFY25

GALTGalectin Therapeutics Inc

3.31▼−5.94%· post 3.31

ClosedOct 30 '26

Mkt cap$334.8MRevenue—Revenue—

Compare

ClosedOct 30 '26

ECORelectroCore, Inc.

GALTGalectin Therapeutics Inc

7.50▼−7.52%post 7.50

Price

3.31▼−5.94%post 3.31

$67.8M

Mkt cap

$334.8M

Q2 FY26$9M

Revenue

—

FY25$32M

Revenue

—

ECOR7.50▼−7.52%vsGALT3.31▼−5.94%ClosedOct 30 '26